The capacity to produce IFN-γ rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice

Journal of Interferon and Cytokine Research

Volumn 20, Issue 1, 2000, Pages 63-77

  Lehmann, Jörg ^a,b   Enssle, Karl Heinz ^c   Lehmann, Irina ^b   Emmendörfer, Andreas ^a   Lohmann Matthes, Marie Luise ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Behringwerke AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ACUTE DISEASE; ANIMALS; ANTIBODIES, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CONVALESCENCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN-4; SPECIFIC PATHOGEN-FREE ORGANISMS; TH1 CELLS; VIRULENCE;

ANIMALIA; LEISHMANIA DONOVANI; MURINAE; PROTOZOA;

EID: 0033974189     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312748     Document Type: Article

References (31)

1. LOCKSLEY, R.M., HEINZEL, F.P., SADICK, M.D., HOLADAY, B.J., and GARDNER, K.D., JR. (1987). Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Past. Immunol. 138, 744-749.
2. + T cells. J. Immunol. 139, 1303-1309.
3. HEINZEL, F.P., SADICK, M.D., HOLADAY, B.J., COFFMAN, R.L., and LOCKSLEY, R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169, 59-72.
4. LOCKSLEY, R.M., and SCOTT, P. (1991). Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. In: Immunoparasitology Today. C. Ash and R.B. Gallagher, eds. Cambridge: Elsevier Trade Journals, pp. A58-A61.
5. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88, 7011-7015.
6. SADICK, M.D., HEINZEL, F.P., HOLADAY, B.J., PU, R.T., DAWKINS, R.S., and LOCKSLEY, R.M. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J. Exp. Med. 171, 115-127.
7. CHATELAIN, R., VARKILA, K., and COFFMAN, R.L. (1992). IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187.
8. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
9. KAYE, P.M., CURRY, A.J., and BLACKWELL, J.M. (1991). Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763-2770.
10. MIRALLES, G.D., STOECKLE, M.Y., MCDERMOTT, D.F., FINKELMAN, F.D., and MURRAY, H.W. (1994). Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect. Immun. 62, 1058-1063.
11. ZWINGENBERGER, K., HARMS, G., PEDROSA, C., OMENA, S., SANDKAMP, B., and NEIFER, S.K. (1990). Determinants of the immune response in visceral leishmaniasis: evidence for pre-dominance of endogenous interleukin 4 over interferon-γ production. Clin. Immunol. Immunopathol. 57, 242-249.
12. GHALIB, H.W., PIUVEZAM, M.R., SKEIKY, Y.A., SIDDIG, M., HASHIM, F.A., EL-HASSAN, A.M., RUSSO, D.M., and REED, S.G. (1993). Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92, 324-329.
13. HOCKERTZ, S., FRANKE, G., PAULINI, I., and LOHMANN-MATTHES, M.L. (1991). Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes. J. Interferon Res. 11, 177-185.
14. BERENS, R.L., and MARR, J.J. (1978). An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J. Parasitol. 64, 160-164.
15. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
16. HÜLTNER, L., MOELLER, J., SCHMITT, E., JÄGER, G.,REISBACH, G., RING, J., and DÖRMER, P. (1989). Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J. Immunol. 142, 3440-3446.
17. OHARA, J., and PAUL, W.E. (1985). Production of a monoclonal antibody to and molecular characterization of B cell stimulatory factor 1. Nature 315, 333-336.
18. RENZ, H., ENSSLE, K., LAUFFER, L., KURRLE, R., and GELFAND, E.W. (1995). Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor (sIL-4R). Int. Arch. Allergy Immunol. 106, 46-54.
19. MOSLEY, B., BECKMANN, P., MARCH, C.J., IDZERDA, R.L., GIMPEL, S.D., VANDEN BOS, T., FRIEND, D., ALPERT, A., ANDERSON, D., JACKSON, J., et al. (1989). The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59, 335-346.
20. HARADA, N., CASTLE, B.E., GORMAN, D.M., ITOH, N., SCHREURS, J., BARRETT, R.L., HOWARD, M., and MIYAJIMA, A. (1990). Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. Proc. Natl. Acad. Sci. USA 87, 857-861.
21. IDZERDA, R.L., MARCH, C.J., MOSLEY, B.M., LYMAN, S.D., VANDEN BOX, T., GIMPEL, S.D., DIN, W.S., GRABSTEIN, K.H., WIDMER, M.B., PARK, L.S., et al. (1990). Human interleukin-4 receptor confers biological responsiveness and defines a novel receptor super family. J. Exp. Med. 171, 861-873.
22. MURRAY, H.W., STERN, J.J., WELTE, K., RUBIN, B.Y., CARRIERO, S.M., and NATHAN, C.F. (1987). Experimental visceral leishmaniasis: production of interleukin 2 and interferon gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon gamma. J. Immunol. 138, 2290-2297.
23. MURRAY, H.W., SQUIRES, K.E., MIRALLES, C.D., STOECKLE, M.Y., GRANGER, A.M., GRANELLI-PIPERNO, A., and BOGDAN, C. (1992). Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 148, 1858-1863.
24. GESSNER, A., SCHROPPEL, K., WILL, A., ENSSLE, K.H., LAUFFER, L., and RÖLLINGHOFF, M. (1994). Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis. Infect. Immun. 62, 4112-4117.
25. SATOSKAR, A., BLUETHMANN, H., and ALEXANDER, J. (1995). Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 63, 4894-4899.
26. SQUIRES, K.E., SCHREIBER, R.D., MCELRATH, M.J., RUBIN, B.Y., ANDERSON, S.L., and MURRAY, H.W. (1989). Experimental visceral leishmaniasis: role of endogenous interferon γ in host defense and tissue granulomatous response. J. Immunol. 143, 4244-4249.
27. MURRAY, H.W., RUBIN, B.Y., and ROTHERMEL, C.D. (1983). Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-γ is the activating lymphokine. J. Clin. Invest. 72, 1506-1510.
28. MURRAY, H.W. (1997). Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J. Infect. Dis. 175, 1477-1479.
29. ENGWERDA, C.R., MURPHY, M.L., COTTERELL, S.E., SMELT, S.C., and KAYE, P.M. (1998). Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol. 28, 669-680.
30. MURRAY, H.W., MIRALLES, G.D., STOECKLE, M.Y., and MCDERMOTT, D.F. (1993). Role and effect of IL-2 in experimental visceral leishmaniasis. J. Immunol. 151, 929-938.
31. HOWARD, M., and O'GARRA, A. (1992). Biological properties of interleukin 10. Immunol. Today 13, 198-200.